Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 6.39% is 553% above its 5-year average of -1.41%, near the high end of its 5-year range (-9.70%–9.04%).
54.07% above its 12-month average of 4.15%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-06-30): 6.13%.
OPERATING MARGIN
6.39%
OPERATING MARGIN AVG TTM
4.15%
OPERATING MARGIN AVG 3Y
-0.83%
OPERATING MARGIN AVG 5Y
-1.41%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+54.07%
CURRENT VS 3Y AVG
+871.53%
CURRENT VS 5Y AVG
+552.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Innovage Holding Corp.
Market Cap
$1.22B
Operating Margin
6.39%
TTM Avg
4.15%
3Y Avg
-0.83%
5Y Avg
-1.41%
Market Cap
$1.22B
Operating Margin
11.12%
TTM Avg
18.27%
3Y Avg
-5.84%
5Y Avg
-26.54%
Market Cap
$1.23B
Operating Margin
-11.96%
TTM Avg
-38.52%
3Y Avg
-75.67%
5Y Avg
-204.09%
Market Cap
$1.23B
Operating Margin
-0.15%
TTM Avg
-15.16%
3Y Avg
-41.30%
5Y Avg
-41.30%
Market Cap
$1.24B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.17B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.16B
Operating Margin
-240.38%
TTM Avg
-171.82%
3Y Avg
-189.28%
5Y Avg
-240.55%
Market Cap
$1.15B
Operating Margin
10.25%
TTM Avg
9.64%
3Y Avg
3.98%
5Y Avg
-5.39%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | 6.39% | 4.15% | -0.83% | -1.41% |
| MannKind Corporation (MNKD)vs › | $1.22B | 11.12% | 18.27% | -5.84% | -26.54% |
| Cronos Group Inc. (CRON)vs › | $1.23B | -11.96% | -38.52% | -75.67% | -204.09% |
| Omada Health (OMDA)vs › | $1.23B | -0.15% | -15.16% | -41.30% | -41.30% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 0.00% | 0.00% | 0.00% | 0.00% |
| Kardigan, Inc. (KARD)vs › | $1.27B | 0.00% | 0.00% | 0.00% | 0.00% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| Nektar Therapeutics (NKTR)vs › | $1.16B | -240.38% | -171.82% | -189.28% | -240.55% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 10.25% | 9.64% | 3.98% | -5.39% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.15B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
21.4%
Operating Margin
6.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 6.13% |
| 2026-03-31 | 9.04% |
| 2025-12-31 | 6.72% |
| 2025-09-30 | 3.51% |
| 2025-06-30 | -4.66% |
| 2025-03-31 | -4.66% |
| 2024-12-31 | -6.01% |
| 2024-09-30 | -2.39% |
| 2024-06-30 | -2.45% |
| 2024-03-31 | -3.00% |
| 2023-12-31 | -0.94% |
| 2023-09-30 | -5.87% |
| 2023-06-30 | -6.19% |
| 2023-03-31 | -4.73% |
| 2022-12-31 | -8.17% |
| 2022-09-30 | -9.70% |
| 2022-06-30 | -7.14% |
| 2022-03-31 | -3.76% |
| 2021-12-31 | 1.68% |
| 2021-09-30 | 6.74% |
| 2021-06-30 | 6.22% |
| 2021-03-31 | -3.43% |
| 2020-12-31 | 13.06% |
| 2020-09-30 | -25.02% |
| 2020-06-30 | 13.23% |
| 2020-03-31 | 8.96% |
